𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy

✍ Scribed by K Hunt; M Vessey; K McPherson; M Coleman

Book ID
118888760
Publisher
Elsevier Science
Year
1988
Tongue
English
Weight
195 KB
Volume
26
Category
Article
ISSN
0020-7292

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cancer incidence and mortality in women
Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapyβ€”long-term follow-up of a Swedish cohort
✍ Ingemar Persson; Jonathan Yuen; Leif Bergkvist; Catherine Schairer πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 741 KB

We analyzed cancer incidence and mortality in a cohort of 22,597 Swedish women who were prescribed replacement hormones. After 13 years of follow-up in national registries, 2,330 incident cancer cases and 848 cancer deaths were observed. Overall, our results were reassuring since incidence rate rati

Risk of cancer in women receiving hormon
Risk of cancer in women receiving hormone replacement therapy
✍ Hans-Olov Adami; Ingemar Persson; Robert Hoover; Catharine Schairer; Leif Bergkv πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 French βš– 828 KB

Cancer risk following treatment with non-contraceptive estrogens was studied in a population-based cohort of 23,244 women. Complete follow-up for an average of 6.7 years revealed 1,087 incident cancers versus 962.5 expected (relative risk/RR/ = 1.13; 95% confidence interval 1.10-1.20). We confirmed

Hormone replacement therapy and incidenc
Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study
✍ Kjersti Bakken; Elin Alsaker; Anne Elise Eggen; Eiliv Lund πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 96 KB πŸ‘ 2 views

## Abstract Increasing use of HRT over the last 2 decades could have contributed to the increasing incidence of cancer in women. Our aim was to investigate the relation between use of HRT and risk of hormone‐dependent cancers in a Norwegian cohort of women. The Norwegian Women and Cancer (NOWAC) st